Medacta Group SA reports significant above-market revenue growth of 16.2% in constant currency in 2024
- Medacta reports 16.2% revenue growth in 2024.
- Strong performance in Knee and Extremities segments.
- 177 new jobs created to support further expansion.
Medacta Group SA / Key word(s): Sales Result Press Release – Ad-hoc announcement pursuant to Art. 53 LR |
Medacta Group SA reports significant above-market revenue growth of 16.2% in constant currency1 in 2024
FY 2024 revenue accelerated to Euro 590.6 million, up 16.2% in c.c.1 or 15.6% in Euro
- Considerable revenue growth across all geographic markets
- Continued outstanding performance in all business lines, particularly in Knee and Extremities
- Expanded focus on medical education during 25th anniversary
- 177 new jobs created to foster further growth
CASTEL SAN PIETRO, 4 February 2025 – Medacta Group SA (“Medacta”, SIX:MOVE) announces today the full year 2024 preliminary unaudited revenue.
Francesco Siccardi, CEO of Medacta, commented: “We are delighted with our sustained excellent growth performance, across all geographic markets and business lines. Our commitment to improve patient outcome and patient satisfaction drives our strong focus on both, out-of-the-box thinking innovations for minimally invasive techniques and personalized solutions as well as on surgeon-specific structured medical education. These are key pillars of our successful strategy. I am proud of our achievement and of the entire Medacta team.”
In 2024, Medacta recorded Group revenue of Euro 590.6 million, an increase of 16.2% in constant currency and an increase of 15.6 % in Euro.
Medacta delivered outstanding growth in all geographic markets and continued excellent growth across all business lines. This was achieved by the continued launch of out-of-the-box thinking innovations across all business lines, the attraction of new surgeons supported by our enlarged sales force and our intensified efforts in medical education. Our 25th Anniversary World Tour provided additional opportunities for in-person scientific events.